期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

口服枸橼酸铁铵对磁共振胰胆管成像的应用价值

下载PDF
导出
摘要 目的研究枸橼酸铁铵(FAC)作为胃肠道阴性对比剂对改善磁共振胰胆管成像(MRCP)质量的价值。方法共收集MRCP病人30例。在服用FAC前、后以相同的采集参数对其行MRCP成像,资深放射科医生对两组图像进行评估。结果口服FAC后,胃肠道信噪比明显减低,胰胆管信噪比无明显变化,MRCP图像的诊断准确率明显提高。结论口服FAC能明显提高MRCP的成像质量及诊断准确率,FAC对MRCP具有一定的临床应用价值。
作者 王岩 刘鹏飞 张波
机构地区 哈尔滨医科大学第一临床医学院磁共振中心
出处 《哈尔滨医科大学学报》 CAS 北大核心 2007年第3期282-283,共2页 Journal of Harbin Medical University
关键词 枸橼酸铁铵 阴性对比剂 磁共振成像 胰胆管造影术
分类号 R445.2 [医药卫生—影像医学与核医学]
  • 相关文献

参考文献5

  • 1Reinhold C,Bret PM.Current status of MR cholangiopancreatography[J].AJR Am J Roentgenol,1996,166(6):1285-1295.
  • 2Barish MA,Soto JA.MR cholangiopancreatography:techniques and clinical applications[J].AJR Am J Roentgenol,1997,169(5):1295-1303.
  • 3Dohke M,Watanabe Y,Okumura A,et al.Anomalies and anatomic variants of the biliary tree revealed by MR cholangiopancreatography[J].AJR Am J Roentgenol,1999,173(5):1251-1254.
  • 4张立娜,徐克,任克,孙文阁,戚喜勋,金安玉,李延亮.使用枸橼酸铁铵抑制3D-MRCP图像中胃肠信号的初步研究[J].中国医学影像技术,2003,19(6):762-764. 被引量：15
  • 5Takahar T,Saeki M,Nosaka S,et al.The use of high concentration of ferric ammonium citrate (FAC) solution as a negative bowel contrast agent:application in MR cholangiography[J].Nippon Igaku Hoshasen Gakkai Zasshi,1995,55(9):697-699.

二级参考文献12

  • 1Wesbey GE, Brasch RC, Goldberg HI, et al. Dilute oral iron solutions as gastrointestinal contrast agents for magnetic resonance imaging: initial clinical experience[J]. Magn Reson Imaging, 1985, 3(1): 57.
  • 2Patten RM, Moss AA, Fenton TA, et al. OMR, a positive bowel contrast agent for abdominal and pelvic MR imaging, safty and imaging characteristics[J]. JMRI, 1992,2(1):25-34.
  • 3Patten RM, Lo SK, Phillips JJ, et al. Positive bowel contrast agent for MR imaging of the abdomen: Phase Ⅱand Ⅲ clinical trials[J]. Radiology, 1993,189(1):227.
  • 4Kivelitz D, Gehl HB, Henck A, et al. Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen, safty and diagnostic efficacy[J]. Acta Radiology, 1999,40(4):429.
  • 5Hirohashi S, Uchida H, Tanaka M, et al. Phase Ⅲ study of an oral abdominal contrast agent containing Ferric ammonium citrate for magnestic resonance imaging(OMR-12200)[J]. Diag Treat, 1992,80(3):168.
  • 6Malcolm PN, Brown JJ, Hahn PF, et al. The clinical value of Ferric ammonium citrate: a positive oral contrast agent for T1-weighted MR imaging of the upper abdomen[J]. JMRI, 2000,12(5):702.
  • 7Yasuhiro O, Yoshihiro N, Kazuo M, et al. Ferric ammonium citrate-cellulose paste for opacification of the esophageal lumen on MRI[J]. Jounal of Computer Assistal Tomography,1996,20(3):455.
  • 8Takahar T, Saeki M, Nosaka S, et al. The use of high concentration of Ferric ammonium citrate(FAC) solution as a negative bowel contrast agent:application in MR cholangiography[J]. Nippon Acta Radiol, 1995,55(9):697.
  • 9Takahar T, Yoshikawa T, Saeki M, et al. High concentration of Ferric ammonium citrate(FAC) solution as a negative bowel contrast agent[J]. Nippon Igaku Hoshasen Gakkai Zasshi, 1995,55(6):425.
  • 10Hirohashi S, Hirohashi R, Uchida H, et al. MR cholangiography and MR urography:Improved enhancement with a negative oral contrast agent[J]. Radiology, 1997,203(1):281.

共引文献14

哈尔滨医科大学学报
2007年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部